智通财经APP讯,亚辉龙(688575.SH)发布公告,公司于近日收到了由广东省药品监督管理局签发的医疗器械注册证,产品名称分别为:25-羟基维生素D(25-OHVD)测定试剂盒(化学发光法)、抗肝/肾微粒体1型IgG抗体测定试剂盒(化学发光法)。
截至目前,公司已先后取得168项化学发光试剂国内《医疗器械注册证》(共241个发光试剂国内注册证)。本次《医疗器械注册证》的取得,有利于进一步丰富公司的全自动化学发光产品线,完善亚辉龙的骨代谢和自身免疫性肝病领域检测套餐,提升公司产品的综合竞争力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.